ConductScience.org, home

Paper21836632

Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.

Harvey TJ and 7 others. Cancer Gene Ther, 2011. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo. Papers, record 21836632. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21836632

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
PubMed
Journal
Cancer Gene Ther
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2026-10-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harvey TJT J
2Hennig IMI M
3Shnyder SDS D
4Cooper PAP A
5Ingram NN
6Hall GDG D
7Selby PJP J
8Chester JDJ D

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenoviridaeMajor topic
Genetic TherapyMajor topic
Hypoxia-Inducible Factor 1Major topic
NitroreductasesMajor topic
ProdrugsMajor topic
Thymidine KinaseMajor topic
Animals
Cell Hypoxia
Cell Line, Tumor
Female
Genetic Vectors
HCT116 Cells
HEK293 Cells
Humans
Immunohistochemistry
Mice
Mice, Inbred BALB C
Simplexvirus
Transfection
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Cancer Research UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116390278Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954.Hum Gene Ther2005https://conductscience.org/library/papers/16390278PubMed
210842200Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase.Int J Cancer2000https://conductscience.org/library/papers/10842200PubMed
310740254Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies.Mol Med Today2000https://conductscience.org/library/papers/10740254PubMed
420539322Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells.Cancer Gene Ther2010https://conductscience.org/library/papers/20539322PubMed
517327829Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy.Mol Ther2007https://conductscience.org/library/papers/17327829PubMed
617440684Hypoxia in cancer: significance and impact on clinical outcome.Cancer Metastasis Rev2007https://conductscience.org/library/papers/17440684PubMed
717523848Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards.Radiat Res2007https://conductscience.org/library/papers/17523848PubMed
815850924Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumor cells.Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/15850924PubMed
912820431Combretastatin A-1 phosphate potentiates the antitumour activity of cisplatin in a murine adenocarcinoma model.Anticancer Res2003https://conductscience.org/library/papers/12820431PubMed
1010455425Insulation of a conditionally expressed transgene in an adenoviral vector.Gene Ther1999https://conductscience.org/library/papers/10455425PubMed
1111241346Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.J Cell Physiol2001https://conductscience.org/library/papers/11241346PubMed
1212239150Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy.Blood2002https://conductscience.org/library/papers/12239150PubMed
1318225594Evaluation of hypoxia-mediated growth factors in a novel bladder cancer animal model.Anticancer Res2007https://conductscience.org/library/papers/18225594PubMed
1419367257A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].Mol Ther2009https://conductscience.org/library/papers/19367257PubMed
1517485316Targeting tumors with hypoxia-activated cytotoxins.Front Biosci2007https://conductscience.org/library/papers/17485316PubMed
168986436Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter.Gene Ther1996https://conductscience.org/library/papers/8986436PubMed
1716391801Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanisms.Int J Oncol2006https://conductscience.org/library/papers/16391801PubMed
1819328781Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.Exp Eye Res2009https://conductscience.org/library/papers/19328781PubMed
1915164095Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.Gene Ther2004https://conductscience.org/library/papers/15164095PubMed
2018772902Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter.Cancer Gene Ther2009https://conductscience.org/library/papers/18772902PubMed

See all 44 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
36717737Suicide gene strategies applied in ovarian cancer studies.Cancer Gene Ther2023https://conductscience.org/library/papers/36717737PubMed
35402634Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles.Mol Ther Methods Clin Dev2022https://conductscience.org/library/papers/35402634PubMed
28627695Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.Int J Oncol2017https://conductscience.org/library/papers/28627695PubMed
28548065Gene Therapy Used in Cancer Treatment.Biomedicines2014https://conductscience.org/library/papers/28548065PubMed
26005859Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo.Gene Ther2015https://conductscience.org/library/papers/26005859PubMed
25377223A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.Invest Ophthalmol Vis Sci2014https://conductscience.org/library/papers/25377223PubMed
23542552The nitroreductase system of inducible targeted ablation facilitates cell-specific regenerative studies in zebrafish.Methods2013https://conductscience.org/library/papers/23542552PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EPO2056PubTator's text mininghttps://conductscience.org/library/genes/2056NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21836632

GET https://conductscience.org/api/papers/v1/21836632/references?page=2